Trademark: 90354504
Word
CNH
Status
Dead
Status Code
606
Status Date
Monday, September 9, 2024
Serial Number
90354504
Mark Type
3
Filing Date
Wednesday, December 2, 2020
Published for Opposition
Tuesday, June 14, 2022
Abandoned Date
Monday, September 9, 2024

Trademark Owner History
CANADIAN NEUTRICEUTICAL HEALTH INC. - Owner At Publication

Classifications
5 Pharmaceutical preparations for skin care; Nutritional supplements in the form of capsules, powder, and gummies; Vitamins; Vitamin supplements; Gummy vitamins; Vitamin supplement patches; Vitamins for pets; Vitamin oils for human consumption; Vitamin fortified beverages for medical purposes; Vitamin enriched bread for therapeutic purposes; Vitamin enriched chewing gum for medical purposes; Mineral supplements; Mineral food supplements; Mineral nutritional supplements; Vitamin and mineral supplements; Enzyme food supplements; Health food supplements; Dietary food supplements; Vitamin tablets; Vitamin preparations; Vitamin drops; Liquid vitamin supplements; Prenatal vitamins; Vitamin preparations in the nature of food supplements; Pharmaceutical preparations, namely, antivirals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Analgesic and muscle relaxant pharmaceutical preparations; Antimicrobial preservatives for cosmetics and pharmaceuticals; Pharmaceutical preparations, namely, appetite suppressants; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical preparations for the treatment of eye diseases and conditions; Dermatological pharmaceutical products; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical preparation for skin care; Pharmaceutical preparations, namely, injectable contraceptives; Potassium preparations for pharmaceutical purposes; Pharmaceuticals, namely, psychotropics; Pharmaceuticals, namely, lipid lowering agents; Pharmaceuticals, namely, inducers of erections; Pharmaceuticals, namely, antihelmintics; Pharmaceutical antitussive-cold preparations; Ocular pharmaceuticals; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations, namely, anticoagulants; Alcohol for pharmaceutical purposes; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cardiovascular disorders; Pharmaceutical preparations, namely, an analgesic for human consumption taken orally; Antibacterial pharmaceuticals; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti - infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Cardiovascular pharmaceuticals; Pharmaceutical preparations for treating and preventing tendon and muscle injuries and disorders, sports related injuries, and for knee cartilage regeneration; Pharmaceutical preparations, namely, a topical preparation for the treatment of ocular disorders prescribed by ophthalmologists, eye surgeons, and optometrists; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; Pharmaceutical preparations for the treatment of inflammatory disorders; Pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for skin wounds; Pharmaceutical preparations for treating dandruff; Pharmaceutical preparations for the treatment of viral infections; Pharmaceutical preparations for treating halitosis; Pharmaceutical preparations for treating hypoglycemia; Pharmaceutical preparations for the treatment of bone fractures; Pharmaceutical preparations for the prevention of osteoporosis; Pharmaceutical preparations for the treatment of hormonal disorders; Pharmaceutical preparations for treating allergic rhinitis; Pharmaceutical preparations for treating asthma; Pharmaceutical products for the treatment of cancer
The mark consists of the wording "CNH" next to a design of two overlapping incomplete ovals.

Trademark Events
Dec 5, 2020
New Application Entered
Feb 8, 2021
New Application Office Supplied Data Entered
Feb 9, 2021
Notice Of Design Search Code E-Mailed
May 19, 2021
Assigned To Examiner
May 28, 2021
Non-Final Action Written
May 28, 2021
Non-Final Action E-Mailed
May 28, 2021
Notification Of Non-Final Action E-Mailed
Nov 18, 2021
Teas Response To Office Action Received
Nov 18, 2021
Correspondence Received In Law Office
Nov 19, 2021
Teas/Email Correspondence Entered
Mar 31, 2022
Assigned To Examiner
Dec 9, 2021
Final Refusal Written
Dec 9, 2021
Final Refusal E-Mailed
Dec 9, 2021
Notification Of Final Refusal Emailed
Jan 25, 2022
Assigned To Examiner
May 3, 2022
Teas Request For Reconsideration Received
May 3, 2022
Correspondence Received In Law Office
May 4, 2022
Teas/Email Correspondence Entered
May 9, 2022
Approved For Pub - Principal Register
May 25, 2022
Notification Of Notice Of Publication E-Mailed
Jun 14, 2022
Published For Opposition
Jun 14, 2022
Official Gazette Publication Confirmation E-Mailed
Aug 9, 2022
Noa E-Mailed - Sou Required From Applicant
Feb 1, 2023
Sou Extension 1 Filed
Feb 1, 2023
Sou Teas Extension Received
Feb 1, 2023
Sou Extension 1 Granted
Nov 28, 2023
Sou Teas Extension Received
Nov 28, 2023
Sou Extension 3 Granted
Nov 30, 2023
Notice Of Approval Of Extension Request E-Mailed
Feb 3, 2023
Notice Of Approval Of Extension Request E-Mailed
Jul 18, 2023
Sou Teas Extension Received
Jul 18, 2023
Sou Extension 2 Filed
Jul 18, 2023
Sou Extension 2 Granted
Jul 20, 2023
Notice Of Approval Of Extension Request E-Mailed
Nov 28, 2023
Sou Extension 3 Filed
Sep 9, 2024
Abandonment - No Use Statement Filed
Sep 9, 2024
Abandonment Notice E-Mailed - No Use Statement Filed
Dec 14, 2023
Case Assigned To Intent To Use Paralegal

Trademark Alertz updated from USPTO on 2030-01-24